Post by
fdfd12 on Mar 21, 2016 7:15am
RBC cuts target
to $68CAN from $77CAN
rating OUTPERFORM
Comment by
stockguy2015 on Mar 21, 2016 7:35am
Ha ha trying to protect themselves if this drops. Then they will put it back up after the release annoying. Still pretty good though at this level
Comment by
cashflow98 on Mar 21, 2016 8:07am
A little lighter than VRX target price chop this morning : 07:01 AM EDT, 03/21/2016 (MT Newswires) -- Valeant Pharmaceuticals International (VRX) shares were downgraded to underperform from neutral by Mizuho Securities and the firm reduced its price target to $18 from $70 a share on Monday. Price: 26.52, Change: -0.46, Percent Change: -1.70 Could me another rough day in HC.
Comment by
green24 on Mar 21, 2016 8:43am
Uggh, the health care sector needs a break from all of this Valent nonsense. Now I see VRX is halted for some reason. I was just looking at the volume chart for CXR. With all of the big red bars last week. You know what stock has almost an identical volume chart? ORT! LOL and never thought I'd see the day. ..